- Home Page
- Company Profile
-
Our Products
- Anti Cancer Capsule
-
Anti Cancer Injection
- 300 mcg Filgrastim Injection
- Nimotuzumab Injection
- 2 Mg Bortezomib Injection
- 440 mg Trastuzumab Injection
- 40 mcg Darbepoetin Alfa Injection
- 1000 mg Gemcitabine Injection
- 38 mg Gemcitabine Injection
- 300 mcg Filgrastim Injection
- 260 mg Paclitaxel Injection
- 450 mg Carboplatin Injection
- 3.75 mg Leuprolide Acetate Injection
- 6 mg Pegfilgrastim Injection
- Pegfilgrastim Injection
- Anti Cancer Tablet
- Anti Cancer Medicine
- Nefroglogy Medicine
- HIV Medicine
- Contact Us
X
38 mg Gemcitabine Injection
2000.00 - 2200.00 INR/Bottle
Product Details:
- Drug Type General Medicines
- Function Anti-Cancer
- Dosage As per doctor Recommendation
- Suitable For Suitable For All
- Storage Instructions Dry place
- Supply Ability : 100 Bottle Per Week
- Click to view more
X
Price And Quantity
- 2000.00 - 2200.00 INR/Bottle
- 25 Bottle
Product Specifications
- Anti-Cancer
- Dry place
- Suitable For All
- As per doctor Recommendation
- General Medicines
Trade Information
- 100 Bottle Per Week
- 1 Days
- Yes
- Contact us for information regarding our sample policy
- All India
Product Description
38 mg Gemcitabine Injection that introduced by us is utilized in the treatment of metastatic or locally advanced bladder cancer in blend with cisplatin. Procured from well-established or authorized pharmaceutical industry, it is formulated and processed with approved method, and using clinically approved compounds, followed by perfectly sealed packaging. In addition to this, the 38 mg Gemcitabine Injection is perfectly tested in well-facilitated laboratory at our steady yet trusted vendor's end.
Other Products in 'Anti Cancer Injection' category
Contact Details
GALAXY LIFE CARE
Plot No 8, Office No 301, 3rd Floor, Chopra Commercial Complex, Delhi - 110092, India
Mr Gopal Jha
(Proprietor)
|
|
|
 |
|
Getdistributors.comSME TimesBlog
India's Largest B2B Marketplace, Connecting Buyers and Sellers.
Privacy Policy- Terms of Use © 1999-2017 Infocom Network Limited. All rights reserved.